Preliminary sales figures of JSC Olainfarm for April 2011 show that sales have grown by 65% compared to April 2010 and have reached 3.38 million lats (4.81 million Euro). The most rapid sales growth was achieved in Kazakhstan (by 157%), Azerbaijan (by 153%), Ukraine (by 133%) and Tajikistan (by 126%). The main sales markets of JSC Olainfarm during April 2011 were Russia, Ukraine, UK, Kazakhstan, Belarus and Latvia.
|April, 2011.||% of total sales||% change to April 2010|
According to preliminary results, during 4 months of 2011 the sales have reached 11.32 million lats (16.11 million Euro), which represents an increase by 39% compared to the first four months of 2010. The biggest sales increases were observed in Canada, where sales have increased more than 30 times, in Bulgaria (by 277%), UK (by 100%), Ukraine (by 95%), Italy (by 89%) and Latvia (by 60%). Major sales markets of JSC Olainfarm during four months of 2011 were Russia, Ukraine, Belarus, UK and Latvia.
|4 months of 2011||% of total sales||% change to 4 months of 2010|
Operating plan and budget of JSC Olainfarm for 2011 provides that company plans the sales of 29.4 million lats (41.8 million Euro) and the net profit of 5.1 million lats (7.3 million Euro).
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Board
Tel: +371 6 7013 717
Cell: +371 2 6448 873